Diversify Advisory Services LLC Takes $908,000 Position in Avantor, Inc. (NYSE:AVTR)

Diversify Advisory Services LLC bought a new position in shares of Avantor, Inc. (NYSE:AVTRFree Report) in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 35,965 shares of the company’s stock, valued at approximately $908,000.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in AVTR. Mesirow Institutional Investment Management Inc. bought a new position in shares of Avantor in the fourth quarter worth about $2,842,000. Raymond James & Associates grew its holdings in Avantor by 84.8% in the 4th quarter. Raymond James & Associates now owns 1,165,646 shares of the company’s stock valued at $26,612,000 after buying an additional 534,901 shares during the last quarter. Federated Hermes Inc. increased its position in Avantor by 19.9% in the 4th quarter. Federated Hermes Inc. now owns 628,189 shares of the company’s stock worth $14,342,000 after buying an additional 104,296 shares during the period. BNP Paribas Financial Markets lifted its holdings in shares of Avantor by 146.1% during the fourth quarter. BNP Paribas Financial Markets now owns 217,296 shares of the company’s stock worth $4,961,000 after buying an additional 129,010 shares during the last quarter. Finally, DAVENPORT & Co LLC boosted its position in shares of Avantor by 17.6% in the fourth quarter. DAVENPORT & Co LLC now owns 2,283,767 shares of the company’s stock valued at $52,430,000 after acquiring an additional 342,452 shares during the period. Institutional investors and hedge funds own 95.08% of the company’s stock.

Avantor Price Performance

NYSE:AVTR opened at $21.03 on Friday. The company has a quick ratio of 1.05, a current ratio of 1.61 and a debt-to-equity ratio of 0.94. The firm has a market cap of $14.29 billion, a PE ratio of 53.92, a price-to-earnings-growth ratio of 2.13 and a beta of 1.32. Avantor, Inc. has a 12 month low of $16.63 and a 12 month high of $26.16. The company’s 50-day moving average price is $23.33 and its two-hundred day moving average price is $23.75.

Avantor (NYSE:AVTRGet Free Report) last announced its earnings results on Friday, April 26th. The company reported $0.22 EPS for the quarter, topping the consensus estimate of $0.20 by $0.02. Avantor had a return on equity of 13.01% and a net margin of 3.79%. The business had revenue of $1.68 billion for the quarter, compared to the consensus estimate of $1.68 billion. During the same period in the previous year, the business earned $0.29 EPS. Avantor’s revenue was down 5.6% compared to the same quarter last year. On average, equities analysts anticipate that Avantor, Inc. will post 1.01 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of equities analysts recently issued reports on AVTR shares. Robert W. Baird dropped their target price on shares of Avantor from $27.00 to $26.00 and set an “outperform” rating on the stock in a research report on Monday, April 29th. Barclays cut their price objective on shares of Avantor from $28.00 to $25.00 and set an “overweight” rating for the company in a research report on Friday, June 28th. Deutsche Bank Aktiengesellschaft lifted their target price on Avantor from $23.00 to $25.00 and gave the stock a “hold” rating in a research report on Thursday, April 18th. Finally, Evercore ISI reduced their price objective on Avantor from $28.00 to $27.00 and set an “outperform” rating for the company in a research report on Tuesday, July 2nd. Four research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $26.29.

Check Out Our Latest Stock Report on Avantor

Avantor Company Profile

(Free Report)

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.

Featured Articles

Institutional Ownership by Quarter for Avantor (NYSE:AVTR)

Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.